Neuromodulation Treatments for Mild Traumatic Brain Injury and Post-concussive Symptoms

Curr Neurol Neurosci Rep. 2022 Mar;22(3):171-181. doi: 10.1007/s11910-022-01183-w. Epub 2022 Feb 17.

Abstract

Purpose of review: Mild traumatic brain injury (mTBI) can result in prolonged post-concussive symptoms (e.g., depression, headaches, cognitive impairment) that are debilitating and difficult to treat. This article reviews recent research on neuromodulation for mTBI.

Recent findings: Transcranial magnetic stimulation (TMS) is the most studied neuromodulation approach for mTBI (four studies for depression, four for headache, one for cognitive impairment, and two for global post-concussive symptoms) with promising results for post-concussive depression and headache. Transcranial direct current stimulation (tDCS) has also been evaluated (one study for post-traumatic headache, and three for cognitive impairment), with more mixed results overall. TMS appears to be a potentially promising neuromodulation treatment strategy for post-concussive symptoms; however, integration into clinical practice will require larger sham-controlled randomized trials with longer and more consistent follow-up periods. Future studies should also explore new stimulation protocols, personalized approaches, and the role of placebo effects.

Keywords: Concussion; Mild traumatic brain injury; Neuromodulation; Transcranial direct current stimulation; Transcranial magnetic stimulation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Concussion* / complications
  • Brain Concussion* / therapy
  • Headache / therapy
  • Humans
  • Post-Concussion Syndrome* / therapy
  • Transcranial Direct Current Stimulation* / methods
  • Treatment Outcome